Allena

Allena is a Massachusetts-based biopharmaceutical company that develops and commercializes oral enzyme therapeutics for the treatment of chronic kidney diseases.

Business Model:

Revenue: $4.4M

Employees: 11-50

Detailed Allena Information

Geographic Data

Allena headquarters map

Address: One Newton Executive Park

City: Newton

State: MA

Zip: 02462

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$3B

Raised Total:

$150M

Metrics

3,638,281Website Global Rank

3,634Website Monthly Traffic

Twitter Followers

Description

Allena is a Massachusetts-based biopharmaceutical company that develops and commercializes oral enzyme therapeutics for the treatment of chronic kidney diseases.

Contact Phone:
+16174674577

Contact Email:

Allena went public on 11/2/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/2/2017

IPO Valuation:
$288M

Ticker Symbol:
ALNA

IPO Price:
$14/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2011 Series A 3 $15M Bessemer Venture Partners
Frazier Healthcare Partners
Third Rock Ventures
Bessemer Venture Partners
Frazier Healthcare Partners
Third Rock Ventures
12/2014 Series B $0 Bessemer Venture Partners
Inbio Ventures
Pharmstandard
HBM Partners
Third Rock Ventures
Frazier Healthcare Partners
Bessemer Venture Partners
Inbio Ventures
Pharmstandard
HBM Partners
Third Rock Ventures
Frazier Healthcare Partners
12/2015 Series C $0 Partner Fund Management
Wellington Management
Fidelity Management and Research Company
Inbio Ventures
Frazier Healthcare Partners
Partner Fund Management
Partner Fund Management
Wellington Management
Fidelity Management and Research Company
Inbio Ventures
Frazier Healthcare Partners
Partner Fund Management
10/2017 IPO -
5/2022 Post-IPO Equity $4.1M
11/2017 Post-IPO Equity 1 - Bessemer Venture Partners
Bessemer Venture Partners
7/2021 Post-IPO Equity $28M
9/2020 Post-IPO Debt 1 $25M Pontifax
Pontifax
Pontifax
Pontifax
5/2022 Post-IPO Equity $2.8B
10/2017 IPO -
12/2015 Series C 5 $53M Partner Fund Management
Wellington Management
Frazier Healthcare
HBM Partners AG
Pharmstandard International, S.A.
Partner Fund Management
Wellington Management
Fidelity Management and Research Company
Inbio Ventures
Frazier Healthcare Partners
Partner Fund Management
11/2017 Post-IPO Equity 1 - Bessemer Venture Partners
Bessemer Venture Partners
12/2014 Series B 6 $25M Bessemer Venture Partners
Inbio Ventures
Pharmstandard
HBM Partners
Bessemer Venture Partners
Inbio Ventures
Pharmstandard
HBM Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research